Verséa Biologics

Verséa Biologics Division, headed by Dr. Sunil J. Panchal, M.D., Ph.D., Chief Scientific Officer, is focused on using the latest cutting-edge scientific advancements in regenerative medicine to provide novel treatment solutions that are fully compliant with the new FDA HCT regulations and use the progenerative power of amnion to help solve wound care, ocular care, and pain management problems.

The portfolio provides reimbursable healthcare options (Medicare & BCBS).


The Verséa Biologics expert team is looking forward to partnering with Pain Management, Podiatrists, Wound Care, and Orthopedic physicians interested in offering effective regenerative medicine treatment options to their patients.

If you want to receive more information about our regenerative, biologics products, let us know!